focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,812.50
Bid: 1,812.50
Ask: 1,813.00
Change: 2.50 (0.14%)
Spread: 0.50 (0.028%)
Open: 1,811.00
High: 1,820.00
Low: 1,803.00
Prev. Close: 1,810.00
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

BUZZ-U.S. STOCKS ON THE MOVE-Coherus, Chesapeake, airline stocks

Wed, 01st Apr 2015 13:20

(For faster updates on individual market-movers, Eikon usersplease use search string "STXBZ US"; for the Day Aheadnewsletter, http://link.reuters.com/mex49s; for the Morning NewsCall newsletter, http://link.reuters.com/nex49s)U.S. stock index futures pointed to a lower open on Wednesday asa weaker-than-expected report on private sector employmentraised concerns that Friday's impending jobs report could alsopoint to worsening conditions in the labor market. Dow Jonesindustrial average e-mini futures were down 0.16 percentat 17,675, S&P 500 futures were down 0.18 percent at2,057 and Nasdaq 100 futures were down 0.11 percent at4,324.75.

** COHERUS BIOSCIENCES INC, Tuesday close$30.58, -3.04 pct premarket

The biotech company priced its offering of 4.1 millionshares at $29 each, a 5 pct discount to stock's Tuesday close.The upsized $120 million offering represents 12 percent of thecompany's outstanding shares as of Feb. 28.

** CHESAPEAKE ENERGY CORP, Tuesday close$14.16, +2.40 pct premarket

The oil and gas producer's Chairman Dunham Archie bought 1million shares at $13.98 per share on March 27, according to aregulatory filing on Tuesday. The purchase price represents a1.3 percent discount to the stock's Tuesday close. After thepurchase, Archie holds 2.6 million shares of the company.

** AMERICAN AIRLINES GROUP INC, Tuesday close$52.78, -2.08 pct premarket

** DELTA AIR LINES INC, Tuesday close $44.96, -2.29pct premarket

** UNITED CONTINENTAL HOLDINGS INC, Tuesday close$67.25, -2.07 pct premarket

Analysts at Deutsche Bank cut ratings on airlines' stocks to"hold" from "buy", saying they expect disappointing earningsgrowth from international markets. The combination of a strongUS dollar, greater-than-expected capacity increases by non-USairlines, and decelerating global GDP growth are likely tofurther pressure Deutsche Bank's forecast (from internationalmarkets) for 2015, analysts write in a note.

** MACERICH CO, Tuesday close $84.33, -5.02 pctpremarket

** SIMON PROPERTY GROUP INC, Tuesday close $195.64

Simon Property Group scrapped its attempt to buy Macerichafter the smaller shopping mall owner rejected its sweetenedoffer of $23.2 billion including debt. Macerich Chief ExecutiveArthur Coppola said the company's board concluded that the offerdid not reflect the full value of the company.

** GLAXOSMITHKLINE PLC, Tuesday close $46.15, +1.41pct premarket

** MERCK & CO INC, Tuesday close $57.48, -0.23 pctpremarket

Cowen & Co analysts said the drugmaker's vaccine totreat shingles may be more effective than Merck's. Glaxo'svaccine HZ/su should be well positioned to capture market sharefrom Merck's Zostavax if final data from a late-stage studyshows HZ/su has better efficacy while treating older patients,analysts said.

** NUVASIVE INC, Tuesday close $45.99, -5.37 pctpremarket

The medical device maker said Chief Executive Office AlexLukianov resigned after an independent investigation showed hehad not complied with the medical device maker's expensereimbursement and personnel policies. NuVasive has appointedboard member Greg Lucier as interim CEO.

** EVERYWARE GLOBAL INC, Tuesday close $1.2, -76.67pct premarket

The marketer of tabletop and food preparation products saidit expects to file for prepackaged bankruptcy that will give itssecured lenders control of the company after it emerges from thebankruptcy. EveryWare said it expects to file for a prepackagedChapter 11 bankruptcy in the U.S. Bankruptcy Court for theDistrict of Delaware and expects to emerge from bankruptcywithin 60-75 days.

** DYAX CORP, Tuesday close $16.755, +49.33 pctpremarket

The drug developer said its experimental drug, DX-2930, toprevent hereditary angioedema attacks, was found effective in anearly stage study. The drug was also assigned fast-track statusby the U.S. FDA. All seven analysts covering the stock raisedprice targets, saying the strong results show the drug couldeclipse the current standard-of-care preventive treatment forHAE.

** UTI WORLDWIDE INC, Tuesday close $12.3, -14.55pct premarket

The logistics company reported a wider-than-expectedfourth-quarter loss, hurt by lower air and ocean freightforwarding yields and lower volumes in freight forwarding. Thecompany also cuts its 2016 adjusted EBITDA forecast to $125million-$150 million from $190 million-$210 million and saidrevenue would be hurt by the strengthening of the dollar.

** SYNNEX CORP, Tuesday close $77.25, -4.21 pctpremarket

The hardware distributor forecast second-quarter revenue andadjusted profit below analysts' average estimates, sayingrevenue is expected to be lowered by about $130 million due tothe stronger dollar. The company on Tuesday also reportedlower-than-expected first-quarter profit and revenue.

** HEWLETT-PACKARD CO, Tuesday close $31.16, +1.67pct premarket

The computer maker has lodged a claim in London againstMichael Lynch and a former colleague for damages of about $5.1billion over their management of Autonomy, the company it boughtin 2011. Lynch will counter sue, seeking in excess of 100million pounds ($149 million) for loss and damage caused by HP'saccusations, his representatives said in a statement on Tuesday.

($1 = 0.6732 pounds)

** SEARS HOLDINGS CORP, Tuesday close $41.38, +8.72pct premarket

The struggling retailer said it would raise more than $2.5billion by selling stores to a real estate investment trust itis setting up, in the latest move to shore up its finances. Thecompany would set up a REIT, Seritage Growth Properties, whichwill buy and lease back about 254 Sears and Kmart stores. Searswill also form a joint venture with mall operator General GrowthProperties under which it will sell 12 stores to the JVfor a 50 percent stake and $165 million in cash.

** CYREN LTD, Tuesday close $3.03, +4.29 pctpremarket

The Israeli cyber security software maker said it received acontract from a UK-based JV between Mitsubishi Heavy IndustriesLtd and Siemens AG.

** VOLTARI CORP, Tuesday close $1.01, +179.21 pctpremarket

Billionaire investor Carl Icahn raises his stake in thedigital advertising company to 52.3 percent. Icahn bought about4 million Voltari shares at $1.36 each via a rights offering.

** MYLAN NV, Tuesday close $59.35, -1.53 pctpremarket

** ABBOTT LABORATORIES, Tuesday close $46.33

The generic drug maker priced an offering of 35 millionshares at $58.35 per share, a discount of about 2 percent to thestock's Tuesday close. All shares in the offering are to be soldby Abbott Laboratories for net proceeds of about $1.99 billion.

** KINDER MORGAN INC, Tuesday close $42.06, +0.43pct premarket

Canada's Keyera Corp and midstream company KinderMorgan plan to build 4.8 million barrels of new crude oilstorage in the marketing hub of Edmonton, Alberta, the twocompanies said on Tuesday.

** CONSOL ENERGY INC, Tuesday close $27.89, +0.32pct premarket

CNX Coal Resources LP, Consol Energy's thermal coal businessformed as a master limited partnership, filed for an initialpublic offering with U.S. regulators on Wednesday, as Consolshifts focus to boosting natural gas production.

** GENERAL ELECTRIC CO, Tuesday close $24.81, -0.36pct premarket

The U.S. conglomerate will commit to financing a new naturalgas plant in Puerto Rico under a debt restructuring planproposed by creditors of the island's struggling power utility,according to plan documents obtained by Reuters.

** SPRINT CORP, Tuesday close $4.74, +0.84 pctpremarket

A plan to salvage RadioShack Corp's business byco-branding most of its 1,740 surviving stores with cellularphone provider Sprint earned U.S. bankruptcy court approval onTuesday, ending four days of contested court hearings.

** TECK RESOURCES LTD, Tuesday close $13.73, +0.51pct premarket

The mining company on Tuesday poured more coldwater on speculation it was in talks to merge with or acquire arival mining company, saying although it had looked atopportunities none have met its criteria.

** LOCKHEED MARTIN CORP, Tuesday close $202.96

The Pentagon's No. 1 defense equipment supplier said itexpected to complete a contract in the coming months to supplyan undisclosed number of PAC-3 missiles to South Korea,following Monday's announcement by that country's defenseacquisition agency.

** CARPENTER TECHNOLOGY CORP, Tuesday close $38.88

The alloys maker said on Tuesday that it will cut about 10percent of its salaried workforce, or 200 jobs, to reduce costsamid weak oil and gas prices. The company will also cut about 60outsourced positions.

** CAMBREX CORP, Tuesday close $39.63

Craig-Hallum Capital Group LLC started coverage of the drugingredient manufacturer with a "buy" rating and price target of$50. Analysts say Cambrex is one of the top 10 contractmanufacturers of small molecule active drug ingredients, amarket they value at over $50 billion with mid-single digitvolume growth. They also expect the company's earnings per shareto double by 2017.

** OFG BANCORP, Tuesday close $16.32

Guggenheim cut its rating on the Puerto Rico-based lender'sstock to "neutral" from "buy".

** CYRUSONE INC, Tuesday close $31.12, +0.80 pctpremarket

** CINCINNATI BELL INC, Tuesday close $3.53

The data center REIT's former parent Cincinnati Bell halvedits stake through a follow-on offering. CyrusOne said it wouldissue 12.2 million shares of common stock to buy an equal amountof Cincinnati Bell's operating partnership units. The offeringwill cut Cincinnati Bell's stake to 22 percent if the full shoeis exercised, and increase the common shares outstanding toabout 53 million.

** ECHO GLOBAL LOGISTICS INC, Tuesday close $27.26

BB&T Capital Markets cut its rating on the logisticscompany's stock to "hold" from "buy".

** GODADDY INC

The web hosting company has priced its initial publicoffering at $20 per share, above its previously indicated $17 to$19 per share range, valuing it at around $4.5 billion,including debt, according to underwriting sources. GoDaddy'sshares are expected to start trading on Wednesday and list onthe New York Stock Exchange under the symbol "GDDY." (Compiled by Ramkumar Iyer in Bangalore; Editing by SimonJennings)

More News
1 Feb 2024 09:03

LONDON BROKER RATINGS: Barclays cuts Next; JPMorgan raises easyJet

(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning:

Read more
1 Feb 2024 07:42

LONDON BRIEFING: Shell profit falls; announces USD3.5 billion buyback

(Alliance News) - Stocks in London are set to follow New York into the red, after the US Federal Reserve quashed hopes of a March cut to interest rates and ahead of the Bank of England interest rate decision.

Read more
31 Jan 2024 17:05

LONDON MARKET CLOSE: Stocks mixed hours before expected US Fed hold

(Alliance News) - Stock prices in London closed mixed on Wednesday in a trade-thinned day ahead of the US Federal Reserve interest rate decision this evening.

Read more
31 Jan 2024 15:49

London close: Stocks mixed ahead of US Fed, BoE decisions

(Sharecast News) - London's financial markets finished with mixed performance on Wednesday, with investors closing their wallets ahead of rate announcements from both the US Federal Reserve and the Bank of England.

Read more
31 Jan 2024 12:05

LONDON MARKET MIDDAY: FTSE 100 flat ahead of Federal Reserve decision

(Alliance News) - The FTSE 100 in London was flat heading into Wednesday afternoon, as the US Federal Reserve's latest interest rate decision edges closer, keeping equity market enthusiasm to a minimum.

Read more
31 Jan 2024 09:13

TOP NEWS: GSK profit up on Arexvy boost in 2023 but total payout down

(Alliance News) - GSK PLC reported an increase in profit and revenue for 2023 as revenue for HIV medicine had stable growth, amid optimism in the company's outlook.

Read more
31 Jan 2024 08:55

LONDON MARKET OPEN: Stocks lack direction ahead of Fed, BoE

(Alliance News) - Stock prices in London lacked direction at the open on Wednesday, as investors nervously look ahead to interest rate decisions from the US Federal Reserve and Bank of England.

Read more
31 Jan 2024 07:46

LONDON BRIEFING: Stocks called up; GSK revenue and profit up

(Alliance News) - Stocks in London are called to open higher, as markets share of nerves around the next set of interest rate decisions.

Read more
29 Jan 2024 08:51

GSK seeks expanded use of RSV vaccine in EU, wins approval for Omjjara

(Alliance News) - GSK PLC on Monday celebrated regulatory progress for two of its products in the EU.

Read more
29 Jan 2024 07:43

LONDON BRIEFING: Superdry looks at saving costs; Ferrexpo loses case

(Alliance News) - Stocks in London are expected to start the week on a cautious note, as investors nervously look ahead to two key interest rate decisions.

Read more
29 Jan 2024 07:07

GSK gets EU approval to sell blood cancer treatment Omijara

(Sharecast News) - Biopharma giant GSK has been given the green light by European regulators to sell Omjjara, its treatment for patients with a rare type of blood cancer.

Read more
26 Jan 2024 10:47

Citi hikes target price for GSK but stays 'neutral'

(Sharecast News) - Shares in biopharma giant GSK were rising on Friday, helped by forecast upgrades from Citi, which raised its target price on the stock from 1,535p to 1,700p.

Read more
24 Jan 2024 15:08

Private equity firm Yellow Wood close to deal to acquire ChapStick-sources

Jan 24 (Reuters) - Private equity firm Yellow Wood Partners is in advanced talks to acquire ChapStick, a lip balm brand, from Haleon Plc, the former consumer health division of drug developer GSK Plc, four people familiar with the matter said.

Read more
24 Jan 2024 14:34

UK earnings, trading statements calendar - next 7 days

Thursday 25 January 
Britvic PLCTrading Statement
Conduit Holdings LtdTrading Statement
CVS Group PLCTrading Statement
Dr Martens PLCTrading Statement
Fevertree Drinks PLCTrading Statement
Foxtons Group PLCFull Year Results
Fuller, Smith & Turner PLCTrading Statement
Halfords Group PLCTrading Statement
Idox PLCFull Year Results
IG Group Holdings PLCHalf Year Results
Intermediate Capital Group PLCTrading Statement
Mitie Group PLCTrading Statement
NCC Group PLCHalf Year Results
Newmark Security PLCHalf Year Results
Next 15 Group PLCTrading Statement
PPHE Hotel Group LtdTrading Statement
Secure Trust Bank PLCTrading Statement
St James's Place PLCTrading Statement
Time Finance PLCHalf Year Results
Titon Holdings PLCFull Year Results
Wizz Air Holdings PLCQ3 Results
Workspace Group PLCTrading Statement
Friday 26 January 
Paragon Banking Group PLCTrading Statement
Record PLCTrading Statement
Superdry PLCHalf Year Results
Taylor Maritime Investments LtdTrading Statement
WH Smith PLCTrading Statement
YouGov PLCTrading Statement
Monday 29 January 
Team Internet Group PLCTrading Statement
Tuesday 30 January 
Diaceutics PLCTrading Statement
Diageo PLCHalf Year Results
Kromek Group PLCHalf Year Results
Luceco PLCTrading Statement
Oxford Cannabinoid Technologies Holdings PLCHalf Year Results
Pets at Home Group PLCTrading Statement
Renewi PLCTrading Statement
Saga PLCTrading Statement
SSP Group PLCTrading Statement
SThree PLCFull Year Results
Synthomer PLCTrading Statement
Wednesday 31 January 
Aberforth Smaller Companies Trust PLCFull Year Results
abrdn Private Equity Opportunities Trust PLCFull Year Results
Ecora Resources PLCTrading Statement
GSK PLCFull Year Results
ITM Power PLCHalf Year Results
NWF Group PLCHalf Year Results
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
22 Jan 2024 21:22

Fate of most remaining Zantac lawsuits weighed by Delaware judge

Jan 22 (Reuters) - GSK, Pfizer and other pharmaceutical companies are urging a judge in Delaware this week to find that evidence plaintiffs' lawyers want to use in about 72,000 lawsuits claiming that the discontinued heartburn drug Zantac caused cancer is not supported by science.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.